A clinical trial of ZMapp, the drug that helped treat Ebola last year, began last Friday in partnership between the National Institute of Allergy and Infectious Diseases and the government of Liberia. ZMapp was developed by a San Diego-based pharmaceutical company, Mapp Biopharmaceutical, and until now, has not been tested in human clinical trials. It […]
